| Prevention and treatment of cardioembolic stroke: a case study. | |
| | |
MedLine Citation:
|
PMID: 20156003 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Ischemic stroke is a medical emergency that requires immediate evaluation and treatment. During the acute phase following stroke, the goal of therapy is reperfusion of the ischemic area with thrombolytic therapy. Blood pressure (BP) goals during the first 24 hours depend on eligibility for tissue plasminogen activator (tPA). Following the acute phase, therapy is directed at prevention of recurrent stroke with antithrombotics and control of ischemic-stroke risk factors. This is a case of a 79-year-old female with newly diagnosed atrial fibrillation who was inappropriately started on aspirin for anticoagulation despite her high risk for stroke. She subsequently suffered a cardioembolic stroke. The patient was not a candidate for tPA because of the inability to determine when symptom onset occurred. Supportive care focused on BP and glycemic control as well as venous thromboembolism prophylaxis. Secondary prevention of stroke for this patient included treatment of hypertension, diabetes, and hypercholesterolemia as well as initiation of warfarin. |
| | |
Authors:
|
Jorie A Glick; Gretchen M Brophy |
Related Documents
:
|
7956383 - Surgical management in patients with coexistent coronary and cerebrovascular disease. l... 23642493 - Clinical outcomes of the realize adjustable gastric band-c at 2 years in a united state... 20338343 - Long-term results after repair of complete atrioventricular septal defect with two-patc... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists Volume: 24 ISSN: 0888-5109 ISO Abbreviation: Consult Pharm Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2010-02-16 Completed Date: 2010-03-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9013983 Medline TA: Consult Pharm Country: United States |
Other Details:
|
Languages: eng Pagination: 903-9 Citation Subset: IM |
Affiliation:
|
Virginia Commonwealth University Health System/Medical College of Virginia Hospitals, Richmond, VA 23298-0533, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aspirin / therapeutic use Atrial Fibrillation / complications*, drug therapy Embolism / drug therapy, etiology, prevention & control Female Fibrinolytic Agents / therapeutic use* Humans Risk Factors Stroke / drug therapy, etiology, prevention & control* Venous Thromboembolism / prevention & control |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; 50-78-2/Aspirin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A treatment algorithm for neuropathic pain: an update.
Next Document: Alternative ways to resolve contract disputes: implications for pharmacists, facilities, and patient...